THE COLUMN GROUP
The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies
THE COLUMN GROUP
Industry:
Biotechnology Finance Financial Services Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
(415) 255-2048
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL GoDaddy EasyDNS
Similar Organizations
Greenoaks Capital
Greenoaks is a global investment firm specializing in technology companies.
Motley Fool Ventures
Motley Fool Ventures is a venture capital that primarily invests in tech-enabled companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Advisors List
Advisor
Current Employees Featured
James Evangelista Chief Financial Officer @ The Column Group
Chief Financial Officer
Larry Lasky Partner @ The Column Group
Partner
2014-01-01
Leon Chen Partner @ The Column Group
Partner
Eric Olson Science Partner @ The Column Group
Science Partner
Sue Murakami Manager of Administration @ The Column Group
Manager of Administration
Carla Daniel Vice President, Head of Talent @ The Column Group
Vice President, Head of Talent
Michael S. Brown Science Partner @ The Column Group
Science Partner
Richard Scheller Science Partner @ The Column Group
Science Partner
David Baltimore Science Partner @ The Column Group
Science Partner
Joseph Goldstein Science Partner @ The Column Group
Science Partner
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-26 | Carmot Therapeutics | The Column Group investment in Series D - Carmot Therapeutics | 160 M USD |
| 2022-05-17 | Remix Therapeutics | The Column Group investment in Series B - Remix Therapeutics | 70 M USD |
| 2022-02-23 | Plexium | The Column Group investment in Series B - Plexium | 102 M USD |
| 2022-02-15 | Kallyope | The Column Group investment in Series D - Kallyope | 236 M USD |
| 2022-01-06 | Eikon Therapeutics | The Column Group investment in Series B - Eikon Therapeutics | 518 M USD |
| 2021-09-22 | Hexagon Bio | The Column Group investment in Series B - Hexagon Bio | 61 M USD |
| 2021-09-09 | Obsidian Therapeutics | The Column Group investment in Series B - Obsidian Therapeutics | 115 M USD |
| 2021-08-26 | Effector Therapeutics | The Column Group investment in Post-IPO Equity - Effector Therapeutics | 60 M USD |
| 2021-08-24 | Atavistik Bio | The Column Group investment in Series A - Atavistik Bio | 60 M USD |
| 2021-08-12 | Surrozen | The Column Group investment in Post-IPO Equity - Surrozen | 120 M USD |
More informations about "The Column Group"
TCG Team | Meet Our Team - The Column Group
Craig Parker joined The Column Group in 2024 as a Venture Partner. He is CEO of Surrozen. Mr. Parker brings more than 25 years of science and business experience across leadership positions in both public and privately-held …See details»
Scientific Visionaries Propelling Life Science Innovation
Jeff Goater joined The Column Group as a Venture Partner in 2021. Previously, he served as Chief Executive Officer of Surface Oncology. During his tenure at Surface, the company fostered an award-winning culture, advanced four …See details»
The Column Group - Crunchbase Investor Profile
The Column Group is a venture capital firm dedicated to creating the next generation of biotechnology companies. They manage over $4 billion in assets and focus on building companies with groundbreaking scientific platforms that …See details»
The Column Group - LinkedIn
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique ...See details»
The Column Group - The Org
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their …See details»
The Column Group (TCG) - Investments, Funds & Exits - InforCapital
The Column Group (TCG) is a venture capital firm focused on building early stage drug discovery companies based on unique scientific platforms and potential breakthrough therapeutics. Their …See details»
The Column Group, LLC - VentureRadar
Jun 3, 2024 The Column Group (TCG) is a science-driven venture capital firm managing $4.0 billion in assets, dedicated to investing in early stage biotechnology companies focused on …See details»
The Column Group - Investments, Portfolio & Company Exits
The Column Group 's most notable exits include Tenaya Therapeutics, ... Which industries has this organization had the most exits in? Show . Tenaya Therapeutics Tenaya Therapeutics a …See details»
Column Group
The Column Group (TCG) is a San Francisco-based, science-driven venture capital firm with $3.5 billion in assets under management. Unlike traditional VC firms, TCG adopts a long-term …See details»
The Column Group Raises $1.23 Billion in Two New Funds
Jun 9, 2022 The Column Group is a leading venture capital firm based in San Francisco that seeks to partner with exceptional scientific founders, entrepreneurs, executives, and …See details»
The Column Group - Funding, Financials, Valuation & Investors
The Column Group is a venture capital firm dedicated to developing biotechnology companies.See details»
The Column Group investment portfolio - PitchBook
Jan 9, 2025 The Column Group General Information Company Description. Founded in 2007, The Column Group is a venture capital investment firm based in San Francisco, California. …See details»
Investing in Medicine with The Column Group - Excedr
The Column Group Team. The Column Group has a diverse group of professionals with varied experience in creating, operating, and funding biotechnology and Life Science companies in …See details»
The Column Group - Org Chart, Teams, Culture & Jobs - The Org
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their …See details»
The Column Group - Overview, News & Similar companies
Feb 27, 2022 The Column Group (TCG) is a leading venture capital firm based in San Francisco that seeks to partner with exceptional scientific founders, entrepr eneurs, executives, and …See details»
Transforming Bold Science into Therapeutic Breakthroughs - The …
Revolution Medicines is an innovative and dynamic organization of expert cellular, structural and computational biologists, medicinal and synthetic chemists, pharmacologists, engineers and …See details»
What are the beliefs of Mahmoud Khalil’s activist group CUAD?
Mar 11, 2025 The group sees the United States as an empire, with their fight within “the belly of the beast” inextricably connected to the fight of Hamas and other terrorist organizations in the …See details»
The Column Group Portfolio Companies - Crunchbase
The Column Group is a venture capital firm dedicated to developing biotechnology companies. This list of organizations invested in by The Column Group provides data on their funding …See details»
U.S. to Withdraw From Group Investigating Responsibility for …
Mar 17, 2025 The U.S. decision to withdraw from the International Center for the Prosecution of the Crime of Aggression against Ukraine, which is part of Eurojust, is expected to be …See details»
TCG | In the News - The Column Group
Feb 1, 2024 The Column Group announces the hiring of Dr. Arnav Mehta. Previously, Dr. Mehta was an Entrepreneur-in-Residence at Third Rock Ventures, a gastrointestinal oncologist at the …See details»